Federal health officials yesterday issued new warnings about the risk of Salmonella illnesses in an ongoing outbreak, with a second brand now linked to some of the infections.

Earlier this month, the Centers for Disease Control and Prevention (CDC) announced a multistate Salmonella I 4:I:- outbreak that had sickened at least 24 people from 14 states and was linked to a Busseto Foods charcuterie sampler sold at Sam's Club stores. In its update yesterday, the CDC said cases have nearly doubled, with 47 cases reported from eight more states.

In the ongoing investigation, interviews with sick patients revealed that four people had bought Fratelli Beretta brand Antipasto Gran Beretta from Costco before they got sick.

The US Department of Agriculture (USDA) Food Safety and Inspection Service (FSIS) said both products were sold as twin packs. Any lot code is potentially contaminated. The products have been removed from store shelves, but health officials are concerned that the products may still be in consumers' refrigerators and recommend throwing the products away.

In its update, the CDC said of 47 patients linked to the outbreak, 10 were hospitalized. No deaths have been reported. Illness onset dates range from November 20, 2023, to January 1.

Minnesota's agriculture department had earlier identified the outbreak strain in an unopened package of Busseto brand charcuterie sampler. Whole-genome sequencing done through the CDC on 46 samples from patients and 1 food sample predicts resistance to ampicillin, kanamycin, streptomycin, and sulfisoxazole. Though most people recover from their Salmonella infections without antibiotics, the CDC warned that some illnesses may be difficult to treat with commonly prescribed antibiotics.

Yesterday in Emerging Infectious Diseases, scientists describe a 2021 COVID-19 outbreak at a beaver farm in Mongolia.

Located in the Bayanzurkh district in Ulaanbaatar, the farm raised 32 adult beavers and 16 kits in 2021 for conservation purposes. The animals lived in a large indoor area separated by waist-high walls.

On August 6, one of the seven farm employees tested positive for COVID-19 after experiencing flu-like symptoms. Three days later, the farm reported the death of two beavers aged 6 months and 2 years after they exhibited cough, nasal discharge, rasping sounds in the lungs and chest, sluggishness, and food aversion.

On August 13, investigators collected nasal swabs, saliva, and tissue from the two dead beavers and obtained nasal samples, saliva, and blood from seven other beavers exhibiting cough and nasal discharge with pus. Later that week and on September 12, the researchers collected more samples from the same animals and from two healthy beavers.

Four unique mutations spark concern

Nearly all (46 of 48) specimens from nine beavers with clinical signs, including the two dead animals, tested positive for COVID-19 on polymerase chain reaction (PCR) testing. Serologic testing of 23 samples revealed the presence of SARS-CoV-2 antibodies in 15. One beaver that didn't show signs of infection also had antibodies.

An alarming aspect of SARS-CoV-2 infection in animals is that host animals can maintain the virus and contribute to the emergence in humans of new variants that have accumulated multiple mutations.

Five random SARS-CoV-2–positive samples were shipped to Austria for whole-genome sequencing, which identified the Delta variant. The Delta and Alpha variants were circulating among people in Mongolia at the time, and the closest related sequences in the beaver samples were from human SARS-CoV-2 in Mongolia, although they contained four novel mutations not found in any public databases as of November 2023.

"An alarming aspect of SARS-CoV-2 infection in animals is that host animals can maintain the virus and contribute to the emergence in humans of new variants that have accumulated multiple mutations," the study authors wrote. "Because the emergence of viruses with mutations not targeted by current SARS-CoV-2 vaccines is a credible possibility, more active surveillance of SARS-CoV-2 infection in animals should be encouraged to identify the appearance of mutated viruses."

A new report from the Government Accountability Office (GAO) urges the US Food and Drug Administration (FDA) to finalize its plan to implement new rules to help identify sources of foodborne illness outbreaks.

The FDA's final rule on food traceability, introduced in November 2022, established a list of certain foods for which enhanced recordkeeping is required, including additional traceability records to track certain points in the item's supply chain—known as critical tracking events. Products that contain dairy, eggs, nuts, prepared food, produce, and seafood are covered by the rule's recordkeeping requirements if that ingredient remains in the form in which it appears on the list, according to the FDA. Examples include fresh lettuce used in a bagged salad mix and a sandwich containing a tomato.

Concerns about complexity, cost

While the FDA says they identified items on the list based on previous outbreaks and the risks they pose to human health, some stakeholders interviewed by the GAO said the list is overly inclusive and have expressed concerns about compliance costs. Although the FDA has taken steps to help industry and non-federal regulators prepare for compliance and has begun the planning process for implementing the rule, which has a compliance date of January 20, 2026, the GAO found that the FDA has not finalized or documented its implementation plan.

The GAO says the finalized plan should address the challenges identified by stakeholders and included additional guidance, training, and tools.

"By finalizing and documenting an implementation plan, FDA will have better assurance it is well positioned to make progress toward its regulatory goals and address the various challenges that stakeholders identified to achieving compliance by the deadline," the GAO said.

Chad, Ivory Coast, the Democratic Republic of the Congo (DRC), Mozambique, Nigeria, and South Sudan all reported new polio cases this week, according to an update yesterday from the Global Polio Eradication Initiative. All involved circulating vaccine-derived poliovirus type 1 (cVDPV1) or type 2 (cVDPV2) and were confirmed in 2023.

Chad confirmed 1 cVDPV2 case in Mandoul, bringing its number of 2023 cases to 51. The DRC reported 4 cVDPV1 cases in Tanganyika, bringing its 2023 cases to 101, and 1 cVDPV2 case in Tshopo, raising the 2023 total to 118. Ivory Coast reported 1 cVDPV2 case in Haut-Sassandra, bringing the country's 2023 cases to 6.

Mozambique had 1 cVDPV1 case in Zambezia, for a total of 4 for 2023. Nigeria confirmed 6 cVDPV2 cases, 1 in Kano and five in Katsina, bringing its 2023 total to 70. And South Sudan recorded 1 cVDPV2 case in Central Equatoria, which doubled its 2023 total.

Afghanistan and Pakistan reported no new wild poliovirus type 1 cases but did report several positive environmental samples.